Yoga Intervention for Cancer Survivors
1 other identifier
observational
48
1 country
1
Brief Summary
Impaired health related quality of life (HRQOL) including fatigue, problems with sleep and psychosocial well being (physical, emotional, and spiritual) have been noted in adult cancer survivors. Physical domain is one of the most common measured indicators of HRQOL. Despite the tremendous implications of having an impaired QOL, few studies have staged interventions aimed at improving HRQOL in a heterogeneous group of cancer survivors. There is little literature examining whether a yoga intervention is feasible in a heterogeneous group of cancer survivors. The proposed research will utilize Vanderbilt Ingram Cancer Center (VICC), Nashville General Hospital (NGH) and REACH for Survivorship program for a pilot study. The investigators will see if a study using a broad range of diagnoses is feasible for a Yoga Intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2010
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2010
CompletedFirst Submitted
Initial submission to the registry
October 15, 2010
CompletedFirst Posted
Study publicly available on registry
October 27, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2012
CompletedApril 6, 2017
April 1, 2017
2.1 years
October 15, 2010
April 5, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Cancer Survivors interested and willing to participate in a 10 week yoga class at Vanderbilt Ingram Cancer Center (VICC) and at Nashville General Hospital
The investigators will be opening up an hourly yoga class for 10 weeks to all cancer survivors at VICC and at Nashville General Hospital
12 months
Secondary Outcomes (1)
Levels of Fatigue using the SF-36 and Psychological Distress using BSI-18
12 months
Study Arms (1)
Yoga Group
Group will enter a 10 week yoga class
Eligibility Criteria
Survivors of Adult or Pediatric Cancer
You may qualify if:
- Survivor population
- Adults (18 years of age or above)
- Patients treated for any cancers between the ages of 18 and 65 years of age
- Received and concluded cancer treatment anytime from January 1, 2000 up to 1 month before start date of study
- Received cancer treatment and care at either Vanderbilt-Ingram Cancer Center (VICC) or Nashville General Hospital (NGH) or are currently receiving cancer survivorship care at the Vanderbilt REACH for Survivorship Clinic
- Obtain \*medical clearance to perform light exercise from primary care physician, oncologist or health care provider at REACH for Survivorship clinic (medical clearance needs to be obtained at least 2 weeks prior to starting yoga class).
- Have completed, if ever received, any chemotherapy treatment from January 1, 2000 up to 1 month before start date of study
- Patients with lymphedema due to cancer surgery/treatment are eligible
- Alive without evidence of recurrent disease
- Without evidence of a subsequent malignancy following initial cancer diagnosis
- Provide informed consent
- Should be able to sit on chair/floor and recline without assistance
- Can read and understand English
- Can have past experience with yoga or meditation
You may not qualify if:
- Enrolled or attending a yoga class at time of recruitment
- Currently receiving active treatment for cancer
- Currently not in remission
- Have any additional health concerns such as brain metastases or ventricular-peritoneal shunts at time of participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Debra L Friedman, MD, MS
Vanderbilt University Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Division Director, Pediatric Hematology/Oncology
Study Record Dates
First Submitted
October 15, 2010
First Posted
October 27, 2010
Study Start
February 1, 2010
Primary Completion
March 1, 2012
Study Completion
March 1, 2012
Last Updated
April 6, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will not share